US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 29, 2013 (13 years ago)

L-ArGiNINE 200 mg/ml Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What was recalled

L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-747-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Arginine recalls

See all
Class II · Moderate risk Ongoing

L-Arginine HCl for Injection

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0056-2026
Class II · Moderate risk Ongoing

L-Arginine for Injection

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0055-2026
Class II · Moderate risk Ongoing

LX Bioboost Plus

Reason Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0477-2025